Sunday, March 4 at the Trans-Pacific Partnership Negotiations in Melbourne, Australia

Today, the United States and other Trans-Pacific Partnership (TPP) partners concluded a fourth day of talks in Melbourne, Australia. Negotiations focused on financial services, investment, temporary entry, and trade remedies. Negotiators also began discussions on regulatory cooperation and trade capacity building.

In addition to today’s negotiations, Australia, the host for the round of negotiations, provided stakeholders on-site the opportunity to share their views directly to the TPP negotiating teams. Approximately 250 stakeholders from a wide range of industry, civil society, and other groups attended, with at least 38 groups making presentations. The presentation schedule is listed below.


Presenter & Organisation


An Indigenous Perspective on the TPPA

Sina Brown-Davis of Ngati Whatua Kaipara descent, Te Ata Tino Toa


O fea iai le Pasefeka? (Where is the Pacific?)

Ali’itasi Esther Stewart, Moana Nui


Jobs, Decent Work and the Trans Pacific Partnership Agreement

Amy Schwebel, ACTU


Bill Rosenberg, NZCTU


Paul Bastian, AMWU


Georgios Altintzis, ITUC


Labour Rights

Mr Trung Doan, Committee to Protect Vietnamese Workers


Regulations for state owned enterprises

Sean Heather, US Chamber of Commerce


SOEs and Privatisation

Professor Jane Kelsey, University of Auckland


Exceptions and Carve-outs: Analysis of Past FTAs and BITs / Case Study for the TPPA

Deborah K. Sy, Harrison Institute Georgetown University Law Center


At the Crossroads: Are the TPP Negotiations Heading Towards Rhetoric or Reality?

Linda Menghetti, Emergency Committee for American Trade and the U.S. Business Coalition for TPP


Investment: priorities for Australian business

Patrick Coleman, Business Council of Australia


Lessons for TPP: How past U.S. FTA financial services and investment rules constrain use of capital controls, prudential financial regulation

Lori Wallach, Public Citizen


Investment rules and investor state dispute settlement in the TPPA: expropriating the right to delegate?

Dr Patricia Ranald, University of Sydney and Australian Fair Trade and Investment Network


Sanya Reld Smith, Third World Network


Kyla Tienhaara, Australian National University


Investment and Services Panel





Investment and trade challenges as a tobacco industry strategy to undermine implementation of the WHO Framework Convention on Tobacco Control: lessons for the TPPA negotiations

Professor Andrew Mitchell, Melbourne Law School


Jonathan Lieberman, McCabe Centre for Law and Cancer, Cancer Council Victoria and Union for International Cancer Control


The merits of including public participation within the Trans-Pacific Partnership Agreement

Rebecca LaForgia, Senior Lecturer Adelaide University Law School


Trade, diets and health - implications for the TPPA

Dr Ann Marie Thow, University of Sydney


Professor Sharon Friel, Australian National University


Globally Integrated Customs and the TPP: an Industry Perspective

Andrew Jackson, IBM


The benefits of services trade reform through the TPP

James Bond, President, Australia Services Roundtable


TPP - A World Class Trade Agreement

Russell Scoular, Ford Asia Pacific & Africa


Ian Mearns, Ford Australia


Agricultural Panel

Charles Mcelhone, National Farmers Federation Australia


Robert Pettit, Dairy Australia


Andrew McCallum, Meat and Livestock Australia


Warren Males, Canegrowers


TPP and IUU – Alphabet Fish Soup

Alistair McFarlane, New Zealand Seafood Industry Council


Insights into sourcing decisions and how to craft an agreement that successfully promotes apparel sourcing in the TPP region

Stan Raggio, Executive Vice-President for Global Sourcing, Gap Inc.



Leigh Obradovic, Distilled Spirits Industry Association of Australia


The Trans-Pacific Partnership and Asia-Pacific Integration

Michael Plummer, Eni Professor of International Economics, The John Hopkins University, SAIS-Bologna

Aspects of the TPP that could affect an open Internet

Susan Chalmers, InternetNZ

Technology Sector Priorities for Promoting ICT and Internet Growth

Greg Slater, Information Technology Industry Council (ITI), Alliance for Network Security (ANS), and Semiconductor Industry Association (SIA)

Fulfilling the Promise of the Digital Age:  Balancing IP Interests

Tim Conway, World Information Technology and Services Alliance (WITSA)


Ray Argall, President Australian Directors Guild

US experience of Internet intermediary liability under the Digital Millennium Copyright Act

Gwen Hinze, Electronic Frontier Foundation

IP Protection and Enforcement

Gina Vetere, US Chamber of Commerce


Kaaren Koomen, (TBA)

US proposal for the intellectual property chapter

Professor Sean Flynn, Associate Director of the Program on Information Justice and Intellectual Property at American University Washington

Issues related to the Intellectual Property provisions of the TPP

Brendan Molloy, Pirate Party

TPPA should promote Access to Knowledge

Krista Cox, Knowledge Ecology International

Ruth Lopert, George Washington University

Ellen Broad, Australian Digital Alliance

Brett Smith, Free Software Foundation


Kate Lynch, CEO of Generic Medicines Industry Association of Australia (GMiA)


Intellectual Property Rights and Pharmaceuticals

Leah Summers, Mylan




Jose Luis Cardenas, Asociacion Industrial de Laboratorios Farmaceuticos (ASILFA)


Faith Wong, Hovid Bhl


Intellectual Property Rights and Pharmaceuticals

Shawn Brown, Generic Pharmaceutical Association of America


Martin Cross, Alphapharm


Maria Fabiana Jorge, MFJ International



Naomi Pearce, Chair IP Working Group of GMiA


Protecting the Pharmaceutical Benefits Scheme in the TPPA

Dr Deborah Gleeson, La Trobe University


Professor Thomas Faunce, College of Law and College of Medicine, Biology and the Environment, Australian National University


Public Health in the Asia-Pacific Region

Peter Maybaruk, Public Citizen


Mary Assunta, Cancer Council Australia


Rob Lake, Australian Federation of AIDS Organisations


Do Dang Dong, Vietnam Network of People Living with HIV


Matthew Cleary, Medicines Sans Frontiers, Australia